---
title: "Xizang Weixinkang Pharmaceutical: Net profit of 183 million yuan in the first half of 2025, a year-on-year increase of 11.82%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254773240.md"
description: "Xizang Weixinkang Pharmaceutical announced that in the first half of 2025, operating revenue was 586 million yuan, a year-on-year decrease of 7.43%. Net profit was 183 million yuan, a year-on-year increase of 11.82%"
datetime: "2025-08-27T09:31:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254773240.md)
  - [en](https://longbridge.com/en/news/254773240.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254773240.md)
generator: "portal-rs"
---

# Xizang Weixinkang Pharmaceutical: Net profit of 183 million yuan in the first half of 2025, a year-on-year increase of 11.82%

Xizang Weixinkang Pharmaceutical announced that in the first half of 2025, operating revenue was 586 million yuan, a year-on-year decrease of 7.43%. Net profit was 183 million yuan, a year-on-year increase of 11.82%

### Related Stocks

- [603676.CN](https://longbridge.com/en/quote/603676.CN.md)

## Related News & Research

- [05:00 ETNorroy Bioscience Initiates Pivotal Phase III Clinical Trial of 177Lu-NYM032, a PSMA-Targeted Radioligand Therapy for mCRPC](https://longbridge.com/en/news/297758164.md)
- [Unigold says Dominican community backs ESIA launch for Neita gold project](https://longbridge.com/en/news/297646851.md)
- [Geiger Makes New Uranium Discovery at the Previously Undrilled Fox Zone, Directly on Trend with Orano's Kiggavik Uranium Deposits | BSENF Stock News](https://longbridge.com/en/news/297633664.md)
- [TKMS says F127 air-defense frigate design advances after customer-driven development work](https://longbridge.com/en/news/297673767.md)
- [06:05 ETKarmanos Now Offers FDA-Approved Daraxonrasib (Rasonque) for Metastatic Pancreatic Cancer](https://longbridge.com/en/news/297497971.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**